Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (18,644) $ (13,307)
Adjustments to reconcile net loss to cash used in operating activities:    
Impairment of intangible assets   146
Impairment of Panacea investment   1,062
Amortization and depreciation 745 810
Amortization of license fees 187 187
Amortization of ROU assets 214 232
Unrealized (gain) loss on investment 2,040 562
Gain on Panacea investment conversion (2,548)  
Gain on the sale of machinery and equipment   (1)
Accretion of non-cash interest expense (income) 13 (222)
Equity-based employee compensation expense 2,871 1,162
Inventory write-off   219
(Increase) decrease in assets:    
Accounts receivable 980 (692)
Inventory (669) (264)
Prepaid expenses and other assets (1,494) (1,754)
Increase (decrease) in liabilities:    
Operating lease obligations (212) (228)
Accounts payable 289 (924)
Accrued expenses (1,422) 481
Accrued severance (285) (88)
Deferred income (272) (5)
Net cash provided by (used in) operating activities (18,207) (12,624)
Cash flows from investing activities:    
Acquisition of patents and trademarks (239) (342)
Acquisition of property, plant and equipment (470) (33)
Sales and maturities of short-term investment securities 52,203 28,960
Purchase of short-term investment securities (84,701) (15,830)
Net cash provided by (used in) investing activities (33,207) 12,755
Cash flows from financing activities:    
Payment on note payable (1,417) (1,269)
Proceeds from note payable issuance 2,653 2,195
Net proceeds from option exercises 1,259  
Net proceeds from warrant exercises 11,782  
Net proceeds from issuance of common stock 38,206  
Taxes paid related to net share settlement of RSUs (469)  
Proceeds from SBA loan   1,183
Repayment of SBA loan   (1,183)
Net cash provided by (used in) financing activities 52,014 926
Net increase (decrease) in cash and cash equivalents 600 1,057
Cash and cash equivalents - beginning of period 1,029 485
Cash and cash equivalents - end of period 1,629 1,542
Net cash paid for:    
Cash paid during the period for interest 26 19
Non-cash transactions:    
Patent and trademark additions included in accounts payable 35 19
Property, plant and equipment additions included in accounts payable 4 9
Property, plant and equipment additions included in accrued expenses 10  
Right-of-use assets and corresponding operating lease obligations 497 198
Patent and trademark additions included in accrued expenses 22 $ 46
Panacea investment conversion $ 12,485